Willow Biosciences Projecting Over $1M in 2Q Revenue | TSX:WLLW, OTCQB:CANSF

Proactive InvestorsJun 27 04:31 ET

Willow Biosciences Brief: Announced Multi-product Development and Licensing Partnership With Laurus Labs for Manufacturing Active Pharmaceutical Ingredients

04:33 PM EDT, 06/26/2024 (MT Newswires) -- Willow Biosciences Brief: Announced multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients

MT NewswiresJun 26 16:33 ET

Willow Biosciences Brief: Announces Its First Patent Being Issued; Anticipates Filing Another Five Patents in 2024 Primarily Related to Its Steroid Production Platform

04:32 PM EDT, 06/26/2024 (MT Newswires) -- Willow Biosciences Brief: Announces its first patent being issued; Anticipates filing another five patents in 2024 primarily related to its steroid productio

MT NewswiresJun 26 16:32 ET

Willow Bioscience Announces 3 Million Dollar Fundraising to Support Partnership With Laurus Labs | TSX:WLLW, OTCQB:CANSF

Proactive InvestorsJun 7 08:19 ET

Willow Biosciences to Launch a $3m Brokered Placement | TSX:WLLW, OTCQB:CANSF

Proactive InvestorsJun 3 03:59 ET

Press Release: WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Canada NewsWire SUNNYVALE, Calif., May 13, 2024 Company continues to advance its corticosteroid product

Dow JonesMay 13 07:00 ET